Search Results - "Schirris, Tom"

Refine Results
  1. 1

    Brothers in Arms: ABCA1- and ABCG1-Mediated Cholesterol Efflux as Promising Targets in Cardiovascular Disease Treatment by Frambach, Sanne J C M, de Haas, Ria, Smeitink, Jan A M, Rongen, Gerard A, Russel, Frans G M, Schirris, Tom J J

    Published in Pharmacological reviews (01-01-2020)
    “…Atherosclerosis is a leading cause of cardiovascular disease worldwide, and hypercholesterolemia is a major risk factor. Preventive treatments mainly focus on…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Ndufs4 knockout mouse models of Leigh syndrome: pathophysiology and intervention by van de Wal, Melissa A E, Adjobo-Hermans, Merel J W, Keijer, Jaap, Schirris, Tom J J, Homberg, Judith R, Wieckowski, Mariusz R, Grefte, Sander, van Schothorst, Evert M, van Karnebeek, Clara, Quintana, Albert, Koopman, Werner J H

    Published in Brain (London, England : 1878) (29-03-2022)
    “…Mitochondria are small cellular constituents that generate cellular energy (ATP) by oxidative phosphorylation (OXPHOS). Dysfunction of these organelles is…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Unlocking mitochondrial drug targets: The importance of mitochondrial transport proteins by Hoogstraten, Charlotte A., Schirris, Tom J. J., Russel, Frans G. M.

    Published in Acta Physiologica (01-06-2024)
    “…A disturbed mitochondrial function contributes to the pathology of many common diseases. These organelles are therefore important therapeutic targets. On the…”
    Get full text
    Journal Article
  6. 6

    Mitoenergetic Dysfunction Triggers a Rapid Compensatory Increase in Steady-State Glucose Flux by Liemburg-Apers, Dania C., Schirris, Tom J.J., Russel, Frans G.M., Willems, Peter H.G.M., Koopman, Werner J.H.

    Published in Biophysical journal (06-10-2015)
    “…ATP can be produced in the cytosol by glycolytic conversion of glucose (GLC) into pyruvate. The latter can be metabolized into lactate, which is released by…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Mitochondrial complex III activity: from invasive muscle biopsies to patient-friendly buccal swab analysis by Somers, Tim, Allard, Neeltje A. E., Siddiqi, Sailay, Janssen, Margit C. M., Hopman, Maria T. E., Morshuis, Wim J., Russel, Frans G. M., Timmers, Silvie, Schirris, Tom J. J.

    Published in Scientific reports (14-06-2023)
    “…Drug-induced mitochondrial dysfunction is a common adverse effect, particularly in case of statins—the most prescribed drugs worldwide. These drugs have been…”
    Get full text
    Journal Article
  10. 10

    Restoring cellular NAD(P)H levels by PPARα and LXRα stimulation to improve mitochondrial complex I deficiency by Frambach, Sanne J.C.M., de Haas, Ria, Smeitink, Jan A.M., Russel, Frans G.M., Schirris, Tom J.J.

    Published in Life sciences (1973) (01-07-2022)
    “…Mitochondrial complex I (CI), the first multiprotein enzyme complex of the oxidative phosphorylation system, plays a crucial role in cellular energy…”
    Get full text
    Journal Article
  11. 11

    Statin Lactonization by Uridine 5′-Diphospho-glucuronosyltransferases (UGTs) by Schirris, Tom J. J, Ritschel, Tina, Bilos, Albert, Smeitink, Jan A. M, Russel, Frans G. M

    Published in Molecular pharmaceutics (02-11-2015)
    “…Statins are cholesterol-lowering drugs that have proven to be effective in lowering the risk of major cardiovascular events. Although well tolerated,…”
    Get full text
    Journal Article
  12. 12

    Statins affect human iPSC-derived cardiomyocytes by interfering with mitochondrial function and intracellular acidification by Somers, Tim, Siddiqi, Sailay, Maas, Renee G. C., Sluijter, Joost P. G., Buikema, Jan W., van den Broek, Petra H. H., Meuwissen, Tanne J., Morshuis, Wim J., Russel, Frans G. M., Schirris, Tom J. J.

    Published in Basic research in cardiology (01-04-2024)
    “…Statins are effective drugs in reducing cardiovascular morbidity and mortality by inhibiting cholesterol synthesis. These effects are primarily beneficial for…”
    Get full text
    Journal Article
  13. 13

    Time to Change: A Systems Pharmacology Approach to Disentangle Mechanisms of Drug-Induced Mitochondrial Toxicity by Hoogstraten, Charlotte A, Lyon, Jonathan J, Smeitink, Jan A M, Russel, Frans G M, Schirris, Tom J J

    Published in Pharmacological reviews (01-05-2023)
    “…An increasing number of commonly prescribed drugs are known to interfere with mitochondrial function, which is associated with almost half of all Food and Drug…”
    Get full text
    Journal Article
  14. 14

    Statins Affect Skeletal Muscle Performance: Evidence for Disturbances in Energy Metabolism by Allard, Neeltje A E, Schirris, Tom J J, Verheggen, Rebecca J, Russel, Frans G M, Rodenburg, Richard J, Smeitink, Jan A M, Thompson, Paul D, Hopman, Maria T E, Timmers, Silvie

    “…Statin myopathy is linked to disturbances in mitochondrial function and exercise intolerance. To determine whether differences exist in exercise performance,…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Metabolic impact of genetic and chemical ADP/ATP carrier inhibition in renal proximal tubule epithelial cells by Hoogstraten, Charlotte A., Jacobs, Maaike M. E., de Boer, Guido, van de Wal, Melissa A. E., Koopman, Werner J. H., Smeitink, Jan A. M., Russel, Frans G. M., Schirris, Tom J. J.

    Published in Archives of toxicology (01-07-2023)
    “…Mitochondrial dysfunction is pivotal in drug-induced acute kidney injury (AKI), but the underlying mechanisms remain largely unknown. Transport proteins…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Effect of statins on mitochondrial function and contractile force in human skeletal and cardiac muscle by Somers, Tim, Siddiqi, Sailay, Janssen, Margit C.M., Morshuis, Wim J., Maas, Renee G.C., Buikema, Jan W., van den Broek, Petra H.H., Schirris, Tom J.J., Russel, Frans G.M.

    Published in Biomedicine & pharmacotherapy (01-11-2024)
    “…The success of statin therapy in reducing cardiovascular morbidity and mortality is contrasted by the skeletal muscle complaints, which often leads to…”
    Get full text
    Journal Article
  19. 19

    Development and validation of a high-content screening in vitro micronucleus assay in CHO-k1 and HepG2 cells by Westerink, Walter M.A., Schirris, Tom J.J., Horbach, G. Jean, Schoonen, Willem G.E.J.

    Published in Mutation research (18-09-2011)
    “…► In drug development assays for the early detection of genotoxicity are needed. ► Two high content screening (HCS) micronucleus assays were developed and…”
    Get full text
    Journal Article
  20. 20

    Uremic solutes modulate hepatic bile acid handling and induce mitochondrial toxicity by Weigand, Karl M., Schirris, Tom J.J., Houweling, Megan, van den Heuvel, Jeroen J.M.W., Koenderink, Jan B., Dankers, Anita C.A., Russel, Frans G.M., Greupink, Rick

    Published in Toxicology in vitro (01-04-2019)
    “…Chronic kidney disease (CKD) is accompanied by accumulating levels of uremic solutes in the circulation. Changes in the size and composition of the bile acid…”
    Get full text
    Journal Article